how to transition from semaglutide to tirzepatide Switching Tirzepatide: 2026 Guide Switching from Semaglutide to Tirzepatide:

Who Shouldnt Use Ozempic Avoid semaglutide if you: Have a personal or family history of medullary thyroid cancer Have Multiple Endocrine Neoplasia syndrome type 2 Are pregnant or planning pregnancy in the near future Have a history of pancreatitis Have severe gastrointestinal disease Your healthcare provider will evaluate whether semaglutide is safe and appropriate for your specific situation

Heimbrgers Post GLP-1s and addiction: lots of promise, but not yet a single robust RCT with a clear clinical outcome

Khlo Kardashian slams mean people accusing her of using weight-loss drug See more of our coverage in your search results

For Laboratory and Scientific Research Use Only

New Jersey-headquartered pharma giant Merck announced Wednesday that it will license a GLP-1 pill for treating obesity from Chinese drugmaker Hansoh whose luck is a blow to investors who placed bets on a much splashier acquisition

Here is a simple guide: Consider Mounjaro if: You want maximum weight loss results You have both obesity and type 2 diabetes You are comfortable with a higher monthly cost You want faster visible results (noticeable from month 2 in many patients) Consider Ozempic if: Budget is a key consideration You have cardiovascular disease (Ozempic has specific heart-protective approvals) You are starting with a lower dose and want to see how your body responds You prefer a medication with a longer track record globally In both cases, you need: A valid prescription from a qualified doctor Regular monitoring and follow-up consultations A structured diet and lifestyle plan alongside the medication Why Doctor Supervision Matters in India Both Mounjaro and Ozempic are Schedule H prescription drugs in India